Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activationNikolaos Patsoukis, Vassiliki A. Boussiotis, Jonathan S. Duke‐Cohan et al.|Communications Biology|2020Cited by 170
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppressionKathleen M. Mahoney, Gordon J. Freeman, Ping Hua et al.|Cancer Immunology Immunotherapy|2018Cited by 141
Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy ResistanceMayinuer Maitituoheti, Kunal Rai, Alvin Shi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 4
Abstract 6425: Functional roles of enhancers in immune microenvironment & immunotherapy responseKunal Rai, Manolis Kellis, Mayinuer Maitituoheti et al.|Cancer Research|2023Cited by 0